AAPL325.13+8.28 (+2.61%) ▲|ABBV259.99+3.57 (+1.39%) ▲|ABT108.93-1.43 (-1.30%) ▼|ACN188.09-1.67 (-0.88%) ▼|ADBE286.08-6.71 (-2.29%) ▼|AMAT441.85-16.54 (-3.61%) ▼|AMD459.61-11.11 (-2.36%) ▼|AMGN438.12+8.24 (+1.92%) ▲|AMT176.02+0.32 (+0.18%) ▲|AMZN254.92-4.85 (-1.87%) ▼|AVGO369.68-0.66 (-0.18%) ▼|AXP324.19-5.98 (-1.81%) ▼|BA205.66-2.12 (-1.02%) ▼|BAC61.99+0.05 (+0.08%) ▲|BKNG195.69-3.40 (-1.71%) ▼|BLK1,128.10-27.51 (-2.38%) ▼|BMY66.92+0.11 (+0.16%) ▲|BNY160.51-0.77 (-0.48%) ▼|BRK-B502.33-1.70 (-0.34%) ▼|C132.54+0.92 (+0.70%) ▲|CAT779.16-18.31 (-2.30%) ▼|CL89.63-0.19 (-0.21%) ▼|CMCSA26.30-0.32 (-1.20%) ▼|COF211.34-3.17 (-1.48%) ▼|COP136.19+3.70 (+2.79%) ▲|COST939.96-3.93 (-0.42%) ▼|CRM258.11+0.57 (+0.22%) ▲|CSCO109.74-0.75 (-0.68%) ▼|CVS97.60+3.69 (+3.93%) ▲|CVX211.05+4.91 (+2.38%) ▲|DE676.08+21.17 (+3.23%) ▲|DHR206.93-6.63 (-3.10%) ▼|DIS106.22-1.33 (-1.24%) ▼|DUK120.39+0.48 (+0.40%) ▲|EMR147.63-4.81 (-3.16%) ▼|FDX324.88-2.52 (-0.77%) ▼|GD369.41-1.94 (-0.52%) ▼|GE331.09-4.62 (-1.38%) ▼|GEV898.53+0.00 (+0.00%) ▲|GILD149.92+3.58 (+2.45%) ▲|GM85.63-0.69 (-0.80%) ▼|GOOG332.03-3.38 (-1.01%) ▼|GOOGL335.02-4.33 (-1.28%) ▼|GS1,002.56-18.34 (-1.80%) ▼|HD319.77-8.06 (-2.46%) ▼|HON209.98-3.55 (-1.66%) ▼|IBM231.40-2.47 (-1.06%) ▼|INTC88.97-0.54 (-0.60%) ▼|INTU344.93-14.37 (-4.00%) ▼|ISRG369.25-7.61 (-2.02%) ▼|JNJ271.19+5.34 (+2.01%) ▲|JPM354.95-1.07 (-0.30%) ▼|KO88.00-0.67 (-0.76%) ▼|LIN486.76-2.82 (-0.58%) ▼|LLY1,160.00+3.27 (+0.28%) ▲|LMT544.50-13.28 (-2.38%) ▼|LOW200.05-4.65 (-2.27%) ▼|LRCX290.20-11.29 (-3.74%) ▼|MA581.10-8.21 (-1.39%) ▼|MCD261.11-0.57 (-0.22%) ▼|MDLZ61.61-0.46 (-0.74%) ▼|MDT92.04+1.39 (+1.53%) ▲|META578.54+6.20 (+1.08%) ▲|MMM170.24-1.59 (-0.93%) ▼|MO69.57+1.09 (+1.59%) ▲|MRK149.86+2.10 (+1.42%) ▲|MS211.04-2.28 (-1.07%) ▼|MSFT501.02-6.27 (-1.24%) ▼|MU933.44-25.29 (-2.64%) ▼|NEE82.93+0.59 (+0.72%) ▲|NFLX80.81-0.24 (-0.30%) ▼|NKE38.12-0.53 (-1.37%) ▼|NOW142.90-5.09 (-3.44%) ▼|NVDA217.44-3.06 (-1.39%) ▼|ORCL141.32-7.80 (-5.23%) ▼|PEP139.79-0.55 (-0.39%) ▼|PFE28.55+0.09 (+0.32%) ▲|PG146.21+1.09 (+0.75%) ▲|PLTR179.92-6.46 (-3.47%) ▼|PM187.15-0.15 (-0.08%) ▼|QCOM166.61-3.87 (-2.27%) ▼|RTX205.16-2.57 (-1.24%) ▼|SBUX106.15-0.10 (-0.09%) ▼|SCHW108.28-1.54 (-1.40%) ▼|SO88.09+0.09 (+0.10%) ▲|SPG211.87-0.45 (-0.21%) ▼|T26.00+0.11 (+0.42%) ▲|TMO600.50-16.60 (-2.69%) ▼|TMUS182.16+1.72 (+0.95%) ▲|TSLA356.09-11.86 (-3.22%) ▼|TXN253.34-7.57 (-2.90%) ▼|UBER75.24-0.41 (-0.54%) ▼|UNH396.30+6.89 (+1.77%) ▲|UNP290.62-10.05 (-3.34%) ▼|UPS102.66-1.57 (-1.51%) ▼|USB61.21-0.37 (-0.60%) ▼|V372.67-6.70 (-1.77%) ▼|VZ50.30+0.28 (+0.56%) ▲|WFC87.04+0.65 (+0.75%) ▲|WMT105.92+1.05 (+1.00%) ▲|XOM164.55+3.60 (+2.24%) ▲|AAPL325.13+8.28 (+2.61%) ▲|ABBV259.99+3.57 (+1.39%) ▲|ABT108.93-1.43 (-1.30%) ▼|ACN188.09-1.67 (-0.88%) ▼|ADBE286.08-6.71 (-2.29%) ▼|AMAT441.85-16.54 (-3.61%) ▼|AMD459.61-11.11 (-2.36%) ▼|AMGN438.12+8.24 (+1.92%) ▲|AMT176.02+0.32 (+0.18%) ▲|AMZN254.92-4.85 (-1.87%) ▼|AVGO369.68-0.66 (-0.18%) ▼|AXP324.19-5.98 (-1.81%) ▼|BA205.66-2.12 (-1.02%) ▼|BAC61.99+0.05 (+0.08%) ▲|BKNG195.69-3.40 (-1.71%) ▼|BLK1,128.10-27.51 (-2.38%) ▼|BMY66.92+0.11 (+0.16%) ▲|BNY160.51-0.77 (-0.48%) ▼|BRK-B502.33-1.70 (-0.34%) ▼|C132.54+0.92 (+0.70%) ▲|CAT779.16-18.31 (-2.30%) ▼|CL89.63-0.19 (-0.21%) ▼|CMCSA26.30-0.32 (-1.20%) ▼|COF211.34-3.17 (-1.48%) ▼|COP136.19+3.70 (+2.79%) ▲|COST939.96-3.93 (-0.42%) ▼|CRM258.11+0.57 (+0.22%) ▲|CSCO109.74-0.75 (-0.68%) ▼|CVS97.60+3.69 (+3.93%) ▲|CVX211.05+4.91 (+2.38%) ▲|DE676.08+21.17 (+3.23%) ▲|DHR206.93-6.63 (-3.10%) ▼|DIS106.22-1.33 (-1.24%) ▼|DUK120.39+0.48 (+0.40%) ▲|EMR147.63-4.81 (-3.16%) ▼|FDX324.88-2.52 (-0.77%) ▼|GD369.41-1.94 (-0.52%) ▼|GE331.09-4.62 (-1.38%) ▼|GEV898.53+0.00 (+0.00%) ▲|GILD149.92+3.58 (+2.45%) ▲|GM85.63-0.69 (-0.80%) ▼|GOOG332.03-3.38 (-1.01%) ▼|GOOGL335.02-4.33 (-1.28%) ▼|GS1,002.56-18.34 (-1.80%) ▼|HD319.77-8.06 (-2.46%) ▼|HON209.98-3.55 (-1.66%) ▼|IBM231.40-2.47 (-1.06%) ▼|INTC88.97-0.54 (-0.60%) ▼|INTU344.93-14.37 (-4.00%) ▼|ISRG369.25-7.61 (-2.02%) ▼|JNJ271.19+5.34 (+2.01%) ▲|JPM354.95-1.07 (-0.30%) ▼|KO88.00-0.67 (-0.76%) ▼|LIN486.76-2.82 (-0.58%) ▼|LLY1,160.00+3.27 (+0.28%) ▲|LMT544.50-13.28 (-2.38%) ▼|LOW200.05-4.65 (-2.27%) ▼|LRCX290.20-11.29 (-3.74%) ▼|MA581.10-8.21 (-1.39%) ▼|MCD261.11-0.57 (-0.22%) ▼|MDLZ61.61-0.46 (-0.74%) ▼|MDT92.04+1.39 (+1.53%) ▲|META578.54+6.20 (+1.08%) ▲|MMM170.24-1.59 (-0.93%) ▼|MO69.57+1.09 (+1.59%) ▲|MRK149.86+2.10 (+1.42%) ▲|MS211.04-2.28 (-1.07%) ▼|MSFT501.02-6.27 (-1.24%) ▼|MU933.44-25.29 (-2.64%) ▼|NEE82.93+0.59 (+0.72%) ▲|NFLX80.81-0.24 (-0.30%) ▼|NKE38.12-0.53 (-1.37%) ▼|NOW142.90-5.09 (-3.44%) ▼|NVDA217.44-3.06 (-1.39%) ▼|ORCL141.32-7.80 (-5.23%) ▼|PEP139.79-0.55 (-0.39%) ▼|PFE28.55+0.09 (+0.32%) ▲|PG146.21+1.09 (+0.75%) ▲|PLTR179.92-6.46 (-3.47%) ▼|PM187.15-0.15 (-0.08%) ▼|QCOM166.61-3.87 (-2.27%) ▼|RTX205.16-2.57 (-1.24%) ▼|SBUX106.15-0.10 (-0.09%) ▼|SCHW108.28-1.54 (-1.40%) ▼|SO88.09+0.09 (+0.10%) ▲|SPG211.87-0.45 (-0.21%) ▼|T26.00+0.11 (+0.42%) ▲|TMO600.50-16.60 (-2.69%) ▼|TMUS182.16+1.72 (+0.95%) ▲|TSLA356.09-11.86 (-3.22%) ▼|TXN253.34-7.57 (-2.90%) ▼|UBER75.24-0.41 (-0.54%) ▼|UNH396.30+6.89 (+1.77%) ▲|UNP290.62-10.05 (-3.34%) ▼|UPS102.66-1.57 (-1.51%) ▼|USB61.21-0.37 (-0.60%) ▼|V372.67-6.70 (-1.77%) ▼|VZ50.30+0.28 (+0.56%) ▲|WFC87.04+0.65 (+0.75%) ▲|WMT105.92+1.05 (+1.00%) ▲|XOM164.55+3.60 (+2.24%) ▲|
20.2 C
New York
Wednesday, September 2, 2026

Tag: cancer

newssourceFORcompanyinformationcontent1releasesmarket

Nektar to Announce Financial Results for the Second Quarter on Thursday, August 7, 2025, After Close of U.S.-Based Financial Markets

SAN FRANCISCO, July 31, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter on Thursday, August 7, 2025, after the...

Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025

REDWOOD CITY, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Coherus, Coherus Oncology or the Company, Nasdaq: CHRS), today announced that its second quarter 2025 financial results will be released after market close on Thursday, August 7, 2025. Starting at 5:00 p.m. EDT on August 7, 2025, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced second quarter 2025 financial results and provided a corporate update.

Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Brazil

MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a supplemental application to ANVISA, the Brazilian health regulatory agency, seeking approval for an additional indication for MINJUVI® (tafasitamab) in combination with rituximab and lenalidomide for the treatment of adult patients with previously treated follicular lymphoma (FL). The supplemental application for the additional indication was selected for review under Project Orbis.

Precipio Announces Q2-2025 Shareholder Update Call

Conference Call to be held on August 14th, 2025 at 5:00 PM EST 
Conference Call to be held on August 14th, 2025 at 5:00 PM EST

El Camino Health Recognized Among Nation’s Best Hospitals by U.S. News & World Report for 2025-2026

Mountain View Top Ranked Community Hospital and #2 Overall in San Jose Metro Area MOUNTAIN VIEW, Calif., July 31, 2025 /PRNewswire/ -- El Camino Health...

Your Tumor’s Best Treatment? A Space-Based Test Could Tell You

With new NASA and NSF funding, Encapsulate is building on its ISS National Lab-sponsored research to bring personalized cancer diagnostics closer to clinical use KENNEDY...

Expert insights about the impact of plastics on health, combating medical misinformation, and implementing AI in the clinic draw nearly 16,500 attendees to ADLM...

CHICAGO, July 31, 2025 /PRNewswire/ -- The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC), welcomed thousands of laboratory experts to ADLM 2025...

CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236

Second patient in the first cohort is now advancing through protocol-defined evaluations as Company provides promising update on first patient pharmacokinetic results

Empower Your Future: Discover Pfizer’s 5-Year Potential with Jessie Harper

Hey, fabulous money mavens! 🌟 Ready for a quick dive into what the future holds for Pfizer? Let’s break it down, Jessie-style, and see...

Energy Fuels Announces Appointment of President

DENVER , July 31, 2025 /CNW/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium, rare earth elements and...

Immunocore to report second quarter 2025 financial results and host call on August 7, 2025

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, July 31, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report second quarter financial results, before the US markets open on Thursday, August 7, 2025.

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCancer

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers